BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1855218)

  • 21. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH; Wallace TL; Richard KA; Tracey DE
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of peritoneal macrophages by oil-attached cell-wall skeleton of BCG and Nocardia rubra.
    Masuno T; Ito M; Ogura T; Hirao F; Yamawaki M; Azuma I; Yamamura Y
    Gan; 1979 Apr; 70(2):223-7. PubMed ID: 381089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activation of bovine macrophage and peripheral blood mononuclear cells by Nocardia rubra cell wall skeleton (N-CWS).
    Yasutomi Y; Onuma M; Yamamoto M; Kawakami Y; Azuma I
    Zentralbl Veterinarmed B; 1990 Nov; 37(9):712-20. PubMed ID: 2267895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of testosterone on growth of P388 leukemia cell line in vivo and in vitro. Distribution of peripheral blood T lymphocytes and cell cycle progression.
    Aboudkhil S; Henry L; Zaid A; Bureau JP
    Neoplasma; 2004; 51(5):368-74. PubMed ID: 15640941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant and antitumor activities of Nocardia cell-wall skeletons.
    Azuma I; Taniyama T; Yamawaki M; Sugimura K; Yamamura Y
    Gan; 1976 Oct; 67(5):733-6. PubMed ID: 797626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superoxide anion and hydrogen peroxide release by macrophages from mice treated with Nocardia rubra cell-wall skeleton: inhibition of macrophage cytotoxicity by a protease inhibitor but not by superoxide dismutase and catalase.
    Ito M; Suzuki H; Nakano N; Yamashita N; Sugiyama E; Maruyama M; Hoshino K; Yano S
    Gan; 1983 Feb; 74(1):128-36. PubMed ID: 6301916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M; Gothoskar BP
    Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of testosterone on growth of P388 leukemia cell line in vivo and in vitro. Distribution of peripheral blood T lymphocytes and cell cycle progression.
    Aboudkhil S; Henry L; Zaid A; Bureau JP
    Neoplasma; 2005; 52(3):260-6. PubMed ID: 15875090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in natural killer cell, antibody-dependent cell-mediated cytotoxicity and interferon activities with administration of Nocardia rubra cell wall skeleton to subjects with high risk of lung cancer.
    Yamakido M; Ishioka S; Onari K; Matsuzaka S; Yanagida J; Nishimoto Y
    Gan; 1983 Dec; 74(6):896-901. PubMed ID: 6199252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of Nocardia rubra cell wall skeleton (Nr-CWS) on oncogenicity of TC-1 cells and anti-human papillomavirus effect of Nr-CWS in lower genital tract of women].
    Zhao J; Zhan SB; Li XQ; Zhou L; Yang YJ; Liao QP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):340-2. PubMed ID: 18322596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
    Maccubbin DL; Mace KF; Ehrke MJ; Mihich E
    Cancer Res; 1989 Aug; 49(15):4216-24. PubMed ID: 2525950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
    Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early macrophage and cytokine response during the growth of immunogenic and non-immunogenic murine tumors.
    Kisseleva E; Becker M; Lemm M; Fichtner I
    Anticancer Res; 2001; 21(5):3477-84. PubMed ID: 11848512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmented production of colony-stimulating factor in C3H/HeN mice immunized with Nocardia rubra cell wall skeleton.
    Hayashi S; Masuno T; Hosoe S; Kawase I; Sakatani M; Ogura T; Kishimoto S; Yamamura Y
    Infect Immun; 1986 Apr; 52(1):128-33. PubMed ID: 3082754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes.
    Masuno T; Hayashi S; Ito M; Ikeda T; Ogura T; Kishimoto S; Yamamura Y
    Cancer Immunol Immunother; 1986; 22(2):132-8. PubMed ID: 3521853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin.
    Cao MY; Lee Y; Feng N; Li H; Du C; Miao D; Li J; Lee V; Jin H; Wang M; Gu X; Wright JA; Young AH
    Cancer Immunol Immunother; 2005 Mar; 54(3):229-42. PubMed ID: 15378281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.